Navigation Links
Finger length points to prostate cancer risk
Date:12/1/2010

Men who have long index fingers are at lower risk of prostate cancer, a new study published today in the British Journal of Cancer has found.

The study led by The University of Warwick and The Institute of Cancer Research (ICR) found men whose index finger is longer than their ring finger were one third less likely to develop the disease than men with the opposite finger length pattern.

"Our results show that relative finger length could be used as a simple test for prostate cancer risk, particularly in men aged under 60," Joint senior author Professor Ros Eeles from the ICR and The Royal Marsden NHS Foundation Trust says. "This exciting finding means that finger pattern could potentially be used to select at-risk men for ongoing screening, perhaps in combination with other factors such as family history or genetic testing."

Over a 15 year period from 1994 to 2009, the researchers quizzed more than 1,500 prostate cancer patients at The Royal Marsden NHS Foundation Trust in London and Surrey, Nottingham City Hospital and The Royal Hallamshire Hospitals in Sheffield, along with more than 3,000 healthy control cases. The men were shown a series of pictures of different finger length patterns and asked to identify the one most similar to their own right hand.

The most common finger length pattern, seen in more than half the men in the study, was a shorter index than ring finger. Men whose index and ring fingers were the same length (about 19 per cent) had a similar prostate cancer risk, but men whose index fingers were longer than their ring finger were 33 per cent less likely to have prostate cancer. Risk reduction was even greater in men aged under 60 years these men were 87 per cent less likely to be in the prostate cancer group.

The relative length of index and ring fingers is set before birth, and is thought to relate to the levels of sex hormones the baby is exposed to in the womb. Less testosterone equates
'/>"/>

Contact: Kate Cox
kate.cox@warwick.ac.uk
44-024-765-74255
University of Warwick
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Prosthesis with information at its fingertips
2. New diagnostic chip able to generate single-cell molecular fingerprints for brain tumors
3. The Rubit Dog Tag Clips Making Big Pet Store Sales, Everyday Dog Ownership Easier, Preventing Broken Fingernails.
4. Real-time, evidence-based information at clinicians fingertips to streamline mental health care
5. Scientists Spot Genetic Fingerprints of Individual Cancers
6. Close Ties With Others Might Lengthen Life, Review Finds
7. Study: Medicare policy may account for growing length of hospice stays in nursing homes
8. Length of biological marker associated with risk of cancer
9. Shorter Telomere Length Again Linked to Cancer
10. Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
11. Texas Childrens Cancer Center first in Texas to magnetically lengthen 9-year-olds leg as she grows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... can be reduced by enabling patients to see the ... This is just one of several recommendations made in ... University of Bristol. , Called ,Primary care factors and ... report has been compiled by researchers from the University,s ... from studies around the world. They found that patients ...
(Date:7/24/2014)... American air and missile defense radar market has been estimated ... a CAGR of 9.64% to reach $340 million by 2020. ... drug trafficking. Brazil is the only market in the region ... radar market. This is followed by Argentina and Chile, which ... in terms of costal surveillance and other air defense radar. ...
(Date:7/24/2014)... July 24, 2014 Dr. Peter Oettgen, ... Deaconess Medical Center in Boston, is the new Deputy ... Oettgen brings his considerable experience in the field to ... . , Dr. Oettgen received his medical degree ... completed his residency at Tufts New England Medical Center. ...
(Date:7/24/2014)... July 24, 2014 Boston Children’s Museum ... Sky, funded by NASA and created through a partnership ... The exhibit is an immersive and inspiring traveling exhibit ... 10, in early investigations of astronomical science. It ... includes a tour of the universe, reveals secrets of ...
(Date:7/24/2014)... protein p53 refers to cancer biology, and the functions ... described in detail. Furthermore, also in cancer biology, it ... tumour cells in order to block their metabolism and ... innovative research on p53 attempts to unveil its functions ... healthy cells. Recent studies with cell cultures have demonstrated ...
Breaking Medicine News(10 mins):Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 3Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 4Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 5Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 3Health News:My Sky Exhibit Opens at Boston Children’s Museum 2Health News:My Sky Exhibit Opens at Boston Children’s Museum 3Health News:My Sky Exhibit Opens at Boston Children’s Museum 4Health News:My Sky Exhibit Opens at Boston Children’s Museum 5Health News:Identified a key molecule in flies that adjusts energy use under starvation conditions 2
... to develop malignancies after radiation treatments , , MONDAY, Feb. ... the success of childhood cancer treatments, researchers report that ... Hodgkin,s disease were almost 40 times more likely to ... cure most patients now who have Hodgkin,s disease. Back ...
... more headaches, new study suggests , , MONDAY, Feb. 16 (HealthDay ... naps to sleep it off, but they run the risk ... perpetuating the cycle of headaches, a new study shows. , ... tried to treat their headaches, and they rated it a ...
... members step down to become observers -SAN DIEGO, ... of wireless, handheld barcode point-of-care (BPOC) solutions ... Laub, Chief Executive Officer of Policy Studies ... Board of Directors. (Logo: http://www.newscom.com/cgi-bin/prnh/20090121/LA60632LOGO )" ...
... AUSTIN, Texas, Feb. 16 In 2007, Bedrest Fitness ... program. The first of its kind, Bedrest Fitness ... or restricted activity can perform to help maintain muscle strength and tone. ... Ejercicios Para ...
... MYL ) announced today that it will host ... 2009, at 5:00 p.m. ET to review the company,s financial ... Mylan will release its financial results on February 19 ... 19 call is 888-287-5536 or 719-325-2126 for international callers. ...
... often deserving 2009 SSI Disability cases will not ... of mistakes made on the disability application. The ... disabled consumers to take additional time ensuring they ... and submitted the proper supporting medical evidence. This ...
Cached Medicine News:Health News:Hodgkin's Survivors Prone to Breast Cancer Later 2Health News:Hodgkin's Survivors Prone to Breast Cancer Later 3Health News:Using Sleep to Manage Headaches May Cause Insomnia 2Health News:Using Sleep to Manage Headaches May Cause Insomnia 3Health News:Margaret Laub Appointed to IntelliDOT Board of Directors 2Health News:Margaret Laub Appointed to IntelliDOT Board of Directors 3Health News:Margaret Laub Appointed to IntelliDOT Board of Directors 4Health News:Spanish Exercise DVD Helps Latinas Reduce Risk of Preterm Labor 2Health News:SSI Disability Application Tips for 2009 2Health News:SSI Disability Application Tips for 2009 3Health News:SSI Disability Application Tips for 2009 4Health News:SSI Disability Application Tips for 2009 5
(Date:7/24/2014)... Lpath, Inc. (NASDAQ: LPTN ... reported interim results in a Phase 2a single-arm, ... a treatment for metastatic renal cell carcinoma (RCC) ... therapy involving a VEGF inhibitor (e.g., Sutent®/ sunitinib ... (e.g., Afinitor®/everolimus), with a maximum of three failed ...
(Date:7/24/2014)... 2014  Market Diagnostics International LLC ("MDxI") today ... , a data resource that sets a new ... and identifying target In Vitro Diagnostics (IVD) customers. ... provides IVD manufacturers with accurate and comprehensive information ... and consistent definitions of laboratory categories and institutional ...
(Date:7/24/2014)... , July 24, 2014   Cypher ... today a co-promotion agreement with Illumina to facilitate ... sequence data for precision medicine and clinical trials. ... companies, through Illumina,s sales force, a solution including ... for data analytics and storage, and Cypher Genomics, ...
Breaking Medicine Technology:Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... evaluation of pancreatic -cell function is not only ... of the natural history of diabetes mellitus, but ... guide to the correct choice of treatment. Peripheral ... function because of the large and variable uptake ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
Medicine Products: